Treatment of central retinal vein occlusion by injection of tissue plasminogen activator into a retinal vein

American Journal of Ophthalmology

Volumn 126, Issue 1, 1998, Pages 142-144

  Weiss, Jeffrey N ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

AGED; ARTICLE; CASE REPORT; CENTRAL RETINA VEIN OCCLUSION; DRUG EFFICACY; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAOCULAR PRESSURE; OPHTHALMOSCOPY; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0031822358     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(98)00086-5     Document Type: Article

References (5)

1. Risk factors for central retinal vein occlusion. Arch Ophthalmol. 114:1996;545-554.
2. Green W.R., Chan C.C., Hutchins G.M., Terry J.M. Central retinal vein occlusion a prospective histopathologic study of 29 eyes in 28 cases . Trans Am Ophthalmol Soc. 79:1981;371-422.
3. Vine A.K., Samama M.M. The role of abnormalities in the anticoagulant and fibrinolytic systems in retinal vascular occlusions. Surv Ophthalmol. 37:1993;283-292.
4. Allf B.F., de Juan E. Jr. In vivo cannulation of retinal vessels. Graefes Arch Clin Exp Ophthalmol. 225:1987;221-225.
5. Steinkamp G.W.K., Hattenbach L.O., Scharrer I., Ohrloff C. Front-loading fibrinolysis with recombinant tissue-plasminogen activator in central or branch retinal vein occlusions. Ophthalmologe. 91:1994;280-282.